Is Once-daily Extended-release Tacrolimus Better than Twice-daily Standard-release Tacrolimus? A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Gu, G. [1 ]
Hang, H. [1 ]
Xia, Q. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-263
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [41] Tacrolimus Requirements during the First Year after Kidney Transplantation (KT): A Comparison between Once-Daily Extended-Release and the Classical Twice-Daily Formulations
    Crespo, Marta
    Mir, Marisa
    Marin, Monica
    Marquez, Eva
    Moral, Ruben
    Puig, Josep M.
    Pascual, Julio
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 469 - 469
  • [42] SAFE CONVERSION OF STABLE KIDNEY TRANSPLANT RECIPENTS FROM TWICE-DAILY TACROLIMUS (Prograf) TO ONCE-DAILY MODIFIED RELEASE TACROLIMUS (Advagraf)
    Carmellini, Mario
    Ruggieri, Giuliana
    Collini, Andrea
    TRANSPLANT INTERNATIONAL, 2011, 24 : 283 - 283
  • [43] Once Daily Extended Release Versus Twice Daily Standard Release Tacrolimus in Kidney Transplant Recipients: A Systematic Review
    Ho, E. T. L.
    Wong, G.
    Chapman, J. R.
    Craig, J.
    TRANSPLANTATION, 2012, 94 (10) : 989 - 989
  • [44] Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies
    Vadcharavivad, Somratai
    Saengram, Warangkana
    Phupradit, Annop
    Poolsup, Nalinee
    Chancharoenthana, Wiwat
    DRUGS, 2019, 79 (18) : 1947 - 1962
  • [45] Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome
    Sforza, D.
    Laria, G.
    Petagna, L.
    Parente, A.
    Anselmo, A.
    Sergi, F.
    Marzio, S.
    Corrado, F.
    Telli, S.
    Manzia, T. M.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (01) : 140 - 142
  • [46] Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation: Prospective Trial in Once-Daily Versus Twice-Daily Tacrolimus
    Tsuchiya, Tomohiro
    Ishida, Hideki
    Tanabe, Tatsu
    Shimizu, Tomokazu
    Honda, Kazuho
    Omoto, Kazuya
    Tanabe, Kazunari
    TRANSPLANTATION, 2013, 96 (02) : 198 - 204
  • [47] CONVERSION FROM TWICE-DAILY TACROLIMUS (TAC-IR) TO ONCE-DAILY EXTENDED RELEASE TACROLIMUS (LCPT) IN EVEROLIMUS TREATED STABLE KIDNEY TRANSPLANT RECIPIENTS
    Cseprekal, Orsolya
    Marton, Adrienn
    Torok, Szilard
    Patonai, Attila
    Foldes, Katalin
    Wagner, Laszlo
    Molnar, Miklos Zsolt
    Mathe, Zoltan
    Kobori, Laszlo
    Remport, Adam
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2090 - 2090
  • [48] CONVERSION FROM A TWICE-DAILY TACROLIMUS-BASED REGIMEN TO ONCE-DAILY TACROLIMUS EXTENDED-RELEASE FORMULATION IN STABLE PEDIATRIC LIVER TRANSPLANT RECIPIENTS: EFFICACY, SAFETY, AND IMMUNOSUPPRESSANT ADHERENCE
    Quintero, Jesus
    Juamperez, Javier
    Sanchez, Marta
    Misercahs, Mar
    Bilbao, Itxarone
    Charco, Ramon
    TRANSPLANT INTERNATIONAL, 2015, 28 : 200 - 200
  • [49] Once-Daily Versus Twice-Daily Tacrolimus Formulations in Liver Transplantation Recipients: A Meta-Analysis.
    Hu, Anbin
    Guo, Zhiyong
    Wu, Linwei
    He, Xiaoshun
    LIVER TRANSPLANTATION, 2012, 18 : S199 - S199
  • [50] Once-daily Extended-Release Pemafibrate Enhances Adherence and Triglyceride Control Over Twice-Daily Dosing
    Akasaki, Yuichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (11) : 1512 - 1514
12345